Animal-assisted therapy improves social behaviors and reduces negative emotions in those with TBI. The findings report those with brain injuries exposed to AAT experienced higher social engagement, satisfaction and motivation following therapy sessions.
According to researchers, a new antibody therapy can help treat TBI and prevent the associated development of Alzheimer's disease and CTE.
Alzheimer's patients who used antipsychotics had a 29% increased risk of head injury and a 22% higher risk of TBI compared to others with the neurodegenerative disease who did not use the medications.
Researchers consider the neurobiology of near death experiences.
Artificial intelligence technology is able to objectively differentiate between those with PTSD and those without by analyzing speech samples, with 89.1% accuracy.
Until now, chronic traumatic encephalopathy could only be diagnosed post-mortem. Researchers have identified a potential biomarker that could help diagnose CTE during a person's lifetime.
CORDIS reports two US based biotech companies have been granted ethical permission to attempt to regenerate the brains of people declared clinically dead from TBI.
People with bipolar disorder have higher incidences of Parkinson's disease than those without the psychiatric condition. Manic and depressive episodes were associated with an elevated risk of developing Parkinson's disease.
According to a new study, veterans exposed to explosions but do not report symptoms to TBI may still have damage to the white matter in their brain.
High levels of SNTF in the blood after TBI correlate with brain tissue damage, researchers discover.
Researchers have developed a new blood test that could help to identify infants who may be experiencing bleeding in the brain as a result of abusive head trauma.
The levels of two protein biomarkers, GFAP and UCH-L1 found in blood samples taken 24 hours after a traumatic brain injury can help to predict which patients will die and which will obtain a severe disability.